Isordil and Phoslo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isordil (isosorbide dinitrate) and Phoslo (calcium acetate). Common drug interactions include vomiting among females and nephrogenic systemic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Isordil and Phoslo. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Isordil?

Isordil has active ingredients of isosorbide dinitrate. eHealthMe is studying from 3,022 Isordil users. Check the latest studies of Isordil.

What is Phoslo?

Phoslo has active ingredients of calcium acetate. eHealthMe is studying from 4,291 Phoslo users. Check the latest studies of Phoslo.



On Jul, 07, 2026

48 people who take Isordil and Phoslo together, and have interactions are studied.

Isordil and Phoslo drug interactions.

What are the common drug interactions of Isordil and Phoslo, by gender? *:

female:

  1. Vomiting
  2. Anaemia (lack of blood)
  3. Bacteraemia (presence of bacteria in the blood)
  4. Cellulitis (infection under the skin)
  5. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  6. Headache (pain in head)
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Activities of daily living impaired
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

male:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Anxiety
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Bradycardia (abnormally slow heart action)
  5. Cerebral atrophy (decrement in size of brain)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Dysarthria (speech disorder)
  8. Emotional distress
  9. Erythema (redness of the skin)
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Isordil and Phoslo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Depression
  4. Disability
  5. Fear
  6. Injury
  7. Multi-organ failure (multisystem organ failure)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Renal injury (kidney injury)

50-59:

  1. Pain
  2. Pain of skin
  3. Scar
  4. Skin exfoliation (removal of the oldest dead skin cells)
  5. Vomiting
  6. Bacteraemia (presence of bacteria in the blood)
  7. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  8. Headache (pain in head)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

60+:

  1. Pneumonia
  2. Cardiac failure congestive
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Renal failure acute on chronic (rapid or long lasting kidney failure)
  6. Serum ferritin increased
  7. Agitation (state of anxiety or nervous excitement)
  8. Cardiac arrest
  9. Cerebral atrophy (decrement in size of brain)
  10. Confusional state

What are the existing conditions these people have? *

  1. High Blood Pressure: 13 people, 27.08%
  2. Diabetes: 11 people, 22.92%
  3. Nuclear Magnetic Resonance Imaging Brain: 9 people, 18.75%
  4. Anaemia (lack of blood): 8 people, 16.67%
  5. Sleep Disorder: 5 people, 10.42%
  6. Pain: 5 people, 10.42%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 10.42%
  8. Chest Pain: 5 people, 10.42%
  9. Pulmonary Embolism (blockage of the main artery of the lung): 3 people, 6.25%
  10. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Isordil and Phoslo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isordil and Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isordil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Phoslo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isordil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phoslo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and calcium acetate (the active ingredients of Isordil and Phoslo, respectively), and Isordil and Phoslo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: